NUTRA PHARMA CORP (NPHC) › Cost of RevenueNUTRA PHARMA CORP (NPHC) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2010: $616.6K2011: $879.6K2012: $147.6K2013: $41.2K2014: $114.3K2015: $65.8K2016: $39.0K2017: $26.9K2018: $68.8K2021: $41.3K2022: $162.8K2023: $177.5K2024: $84.8K2025: $183.7K$183.7K2010Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$183.7K+116.5%2024$84.8K-52.2%2023$177.5K+9.0%2022$162.8K+294.6%2021$41.3K—2018$68.8K+155.6%2017$26.9K-31.0%2016$39.0K-40.8%2015$65.8K-42.4%2014$114.3K+177.7%2013$41.2K-72.1%2012$147.6K-83.2%2011$879.6K+42.6%2010$616.6K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share